Nullane salus extra ecclesiam
Randomized clinical trials are not relevant for infectious disease outbreaks due to a new pathogen, for which public health decisions have to be made urgently. An approach based on group comparisons, in silico, may provide valuable results in a reasonably short period of time for a negligible amount...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | New Microbes and New Infections |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2052297520300664 |